Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol crossover trial in chronic kidney disease with asymptomatic hyperuricemia
2013-001640-56Phase 2Active
- Sponsor
- Fundación para la Investigación Biomédica de Córdoba
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of allopurinol in chronic kidney disease (CKD) and hyperuricemia (2 arms), sponsored by Fundación para la Investigación Biomédica de Córdoba. Primary endpoints: C-reactive protein, Interleukin-1 and 6 more. Started Sep 2013; status: active.
02
Drugs
allopurinol
03
Conditions
chronic kidney disease (CKD)hyperuricemia
Beyond the preview
Go deeper on 2013-001640-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001640-56.